Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Substance Use Disorders > Opioid Use Disorder Treatments > Flashcards

Opioid Use Disorder Treatments Flashcards

(55 cards)

Start Studying
1
Q

Psychosocial treatments for OUD may include…

A

Psychotherapy
CBT
Structured counselling + motivational interviewing
Case+ + contingency management, care coordination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Addictions and substance use disorders are often associated with…

A

Trauma and psychiatric disorders

Substance is often used as a coping mechanism for trauma + psych conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

For any substance use disorder, we should start with…

A

The person - underlying conditions, rather than the medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Withdrawal management is simply…

A

Helping the individual to deal with withdrawal symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Withdrawal management alone is ____, because..

A

Not effective and is associated with risks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Withdrawal management alone may be a potential option for someone with…

A

Mild OUD, and is undergoing proper psychosocial supports (and does not want to undergo long-term agonist treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Withdrawal mangement/detox alone is associated with…

A

Increased HIV and HCV transmission
Increased relapse rates
Increased morbidity and mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Naltrexone affects opioid receptors by…

A

Being a full opioid receptor antagonist that blocks euphoric effects of opioids

Oral formulation of naloxone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Oral naltrexone could be considered as…

A

An adjunct treatment upon cessation of opioid use

This is a weak recommendation with low quality evidence; if patient is deficient of endogenous opioid, this would not be helpful to treat that deficit.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Benefits of using naltrexone for OUD include…

A

Ease of administration
No induced tolerance during prolonged treatment
No potential for dependence/misuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Risks with using naltrexone involve…

A

A higher risk of overdose for patients who stop treatment, and relapse to opioid use due to decrease in tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A meta-analysis found that oral naltrexone found ____ compared to placebo.

A

No significant difference in retention or abstinence rates

ER-naltrexone monthly did show increased retention in tx, increased abstinence rates, and decreased opioid cravings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The most desired treatment for OUD is…

A

Opioid agonist therapy (OAT)

Give patient safe levels of opioid to try and help reduce cravings/withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The dose of suboxone is based on…

A

The buprenorphine component

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

1st line treatment for OUD is…

A

Buprenorphine/naloxone (Suboxone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

2nd line for OUD treatment is…

A

Methadone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

3rd line for OUD treatment is…

A

Slow-release oral morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The purpose of naloxone in the suboxone formulation is to…

A

Prevent diversion of suboxone - cannot be crushed/snorted for effect, has no effect unless injected and may negate opiate effect if injected

Oral/sublingual naloxone is NOT absorbed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Buprenorphine is available in different formulations, such as…

A

Patches - indicated for pain, not OUD
Buccal films or sublingual tablets, + naloxone (suboxone)
XR injection (Sublocade), OUD monthly injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Buprenorphine has ____ affinity for Mu opioid receptors, which affects other opiates by…

A

High affinity (strong binding ability). Will displace heroin/other opiates from their receptors and block their effects, also protecting from overdose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Buprenorphine is a ____ at the Mu opioid receptors and an ____ at the Kappa and Delta opioid receptors

A

Partial agonist at Mu opioid-receptor
Antagonist at Kappa + Delta opioid receptors

Antagonism at kappa + delta may benefit mood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Buprenorphine has a slow dissociation from the opioid receptor which means…

A

Duration of action increases with increases in dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Partial agonism of buprenorphine means…

Study These Flashcards
A

Opiate has a ceiling effect - no further opioid effect above a certain dose.
Also safer in overdose

Overdose still possible if patient is opioid naive

24
Q

Common AE’s with bup/nal include…

Study These Flashcards
A

Headache, pain, withdrawal syndrome
Nausea, constipation, abdominal pain,
Insomnia
Runny nose, sweating

Similar to other opioids, usually better tolerated

Withdrawal symptoms are involved due to partial agonism (especially when switching from a full agonist opioid

25
Some rarer AE's that may occur with bup/nal include...
Flu-like symptoms, muscle aches Tooth disorder, dyspepsia Psych - Depression, anxiety, nervousness, somnolence, dizziness, paresthesia
26
Notable DI's with bup/nal include...
Usage of opioids for analgesia: diminished effect and may require reassessment in acute pain Alcohol, BZD's - increased risk of respiratory depression (less than full opioid agonists) ## Footnote Diminished analgesia due to Mu-receptor occupation
27
Advantages of bup/nal over methadone include...
Lower risk of overdose, better safety profile Less AE's Lower risk of diversion Less DI's Milder withdrawal sx's when discontinued ## Footnote Methadone is a CYP drug Slow dissociation means milder withdrawal symptoms
28
Suboxone efficacy compared to methadone is...
No significant difference in terms of treatment retention at medium/high doses of suboxone. No difference between the two in decreasing illicit opioid use
29
Notable counselling points regarding suboxone administration include...
Dissolve under tongue, which may take up to 10 minutes. Avoid eating + drinking during this time **No therapeutic effect if swallowed**
30
Precipitated withdrawal is anticipated when switching a patient from full opioid agonist to bup/nal because...
Buprenorphine displaces full opiate agonists from their receptors and partially activates receptor compared to full agonists - overall net decrease in receptor activation will cause withdrawal symptoms
31
Precipitated withdrawal can occur ____ after the 1st dose of bup/nal.
30-60 minutes
32
Ways to minimize risk of precipitated withdrawal include...
Delaying 1st dose until moderate withdrawal is experienced Start with low dose, communicate risk, and monitor patient Micro-dosing induction
33
COWS is...
Clinical Opiate Withdrawal Scale
34
When waiting for a patient to experience moderate withdrawal to induce bup/nal, their COWS score should be...
Greater than 12 | Adjuvant agents could be given to help patient with withdrawal sx's ## Footnote Does require patient to be moderately uncomfortable and may decrease buy-in to treatment
35
In general, the duration of time between last opioid dose and onset of moderate withdrawal (COWS greater than 12) is usually...
Short-acting: 12-16 hours Intermediate-acting: 17-24 hours Long-acting: 30-36 hours or more
36
Microdosing bup/nal is a strategy to avoid precipitated withdrawal by...
Accumulation of buprenorphine at receptor due to long t1/2 - very small doses should not precipitate withdrawal. Overtime, an increasing amount of full agonist will be replaced by buprenoprhine at receptor ## Footnote Full opioid dose they have been using is usually continued
37
Most regimens involved with microdosing suggest increasing the dosage of bup/nal daily for ____ days, and stopping full agonist on...
7 days. Stopping full agonist on the 8th day
38
Methadone MOA is...
Full opioid agonist
39
Methadone should be tried for individuals who...
Respond poorly to bup/nal, or when bup/nal is not the preferred option
40
Compared to suboxone, methadone has potentially better retention rates in people with...
Moderate-severe OUD Long history of OUD Heroin addiction ## Footnote May also be considered for those who are severely unstable and would be at great risk for harm if lost to follow up
41
Onset of methadone is...
0.5-1 hour
42
Duration of action for methadone is...
For analesia ~4-8 hours OAT 22-48 hours with repeated dosing
43
Half life of methadone is ____, which is significant because...
24-36 hours (range of 8-59), drug can accumulate and cause opioid toxicity if doses are increased too fast
44
AE's of methadone include... | Typical opioid AE's - full agonist
CNS depression (somnolence, mild cognitive dysfunction), agitation Nausea, constipation Hormonal dysfunction Weight gain, tooth decay QT prolongation
45
Notable DI's with methadone involve...
Anything with CYP3A4 and 2D6 Additive QT prolongation and CNS depressive agents Anything that increases risk of serotonin syndrome
46
____ doses of methadone are more effective, but dosing should be based on...
Higher doses - should be based on clinical judgement due to differences in metabolism, co-morbidities, and DI's ## Footnote Example of co-morbidities = liver disease, QT prolongation
47
Methadone doses should not be adjusted sooner than ____ due to...
Every 5 days, due to long half-life (risk of accumulation
48
Methadone dose titrations need to be restarted after missing ____ days, due to...
3 days: due to loss of tolerance, avoid opioid toxicity
49
Methadone formulations are available as... | AKA methadose
10 mg/mL oral concentrates ## Footnote One is red, cherry-flavoured and the other is dye-free, sugar-free, unflavoured
50
Slow-release oral morphine (SROM) can be considered for patients...
When 1st and 2nd line treatment options are ineffective or CI
51
Efficacy of SROM compared to methadone...
Is similar; no difference in tx retention but higher AE's ## Footnote Less overall evidence available for SROM
52
The only SROM that has been studied is the ____ release product, and should be adjusted no sooner than...
24 hour release product; adjusted no sooner than q48 hours | Due to elimination half-life of 11-13 hours
53
To reduce risk of diversion of SROM, it should first be prescribed as...
Once-daily witnessed doses
54
Individuals with severe OUD who inject opioids may not adequately benefit from oral OAT for a variety of reasons, such as...
Having cravings despite optimal OAT dosing Inability to reach therapeutic dose Insufficient improvements in health, social fx, or QoL Opting not to initiate oral OAT
55
Meta-analyses found that in individuals that are tx refractory to methadone, Rx injectable diacetylmorphine is beneficial in reducing... | Canada = IV hydromorphone
Illicit opioid use Premature tx discontinuation Criminal activity Incarceration Mortality ## Footnote Improvement in overall health + social functioning

Substance Use Disorders (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions